Protease-activated receptor 2-dependent fluid secretion from airway submucosal glands by house dust mite extract

Hyung-Ju Cho1, Hyun Jae Lee, Sang Cheol Kim

  • 1Department of Otorhinolaryngology, Kang-Dong Sacred Heart Hospital, Hallym University College of Medicine, Seoul, Korea.

Abstract

Insights

House dust mites (HDMs) trigger airway submucosal gland secretion in allergic rhinitis and chronic rhinosinusitis patients. Protease-activated receptor 2 (PAR2) mediates this response, suggesting a target for airway hyperreactivity.

Area of Science:

  • Respiratory Medicine
  • Immunology
  • Cell Biology

Background:

  • Submucosal glands (SMGs) regulate airway surface fluid.
  • Protease-activated receptor 2 (PAR2) is implicated in allergic inflammation.
  • House dust mites (HDMs) possess proteases that activate PAR2, but their direct impact on SMG secretion is unclear.

Purpose of the Study:

  • To investigate the effect of HDMs on glandular secretion.
  • To elucidate the underlying mechanisms in allergic rhinitis (AR) and chronic rhinosinusitis (CRS) patients.

Main Methods:

  • Nasal turbinates from 55 patients (control, AR, CRS, AR+CRS) were analyzed.
  • SMG secretion was quantified using microscopy after stimulation with HDM extract, PAR2-activating peptide, and carbachol.
  • PAR2 expression in SMGs was assessed via immunostaining.

Main Results:

  • HDMs significantly increased SMG secretion in AR and AR+CRS groups.
  • CRS patients without HDM-specific IgE also showed increased secretion, suppressed by a PAR2 antagonist.
  • PAR2-activating peptide mimicked HDM effects, and PAR2 was highly expressed in all disease groups.

Conclusions:

  • HDM allergens induce glandular secretion in patients with AR, CRS, or both.
  • PAR2 activation is a key mechanism for HDM-induced secretion.
  • PAR2 may contribute to nonspecific hyperreactivity in inflammatory airway diseases.

Related Concept Videos

Allergic Reactions02:06

Allergic Reactions

Overview
26.7K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.5K
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.7K
Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
311